$ 751 0 m
14 0 %
South African life insurer AllLife has rewritten the rule book on insuring people living with diseases that previously excluded them from buying life insurance. Launched in 2004, it first offered cover for people living with HIV, building a profitable business from policyholders neglected by the insurance industry. It subsequently expanded its product offering to provide cover for people living with diabetes.
Providing more than just insurance, AllLife links its insurance products to a health management program which actively helps its customers manage their health, while simultaneously improving AllLife’s risk profile.
LeapFrog’s first impact investment was in AllLife in 2009. Since then, we have worked closely with the business in underwriting, product design and operations, enabling AllLife to grow its client base and expand into new markets.
In 2017 AllLife signed a deal with UK life insurer Royal London, which now uses its proprietary insuretech risk assessment and underwriting system to provide capped-price life insurance to people in the UK living with diabetes. This deal is the first step in AllLife’s long-held ambition to open up access to life insurance cover for people around the world living with chronic diseases.
AllLife is one of many LeapFrog investments in financial services. Read more about our work in the sector.